High expression of OX40 (CD134) and 4-1BB (CD137) molecules on CD4+CD25high cells in children with type 1 diabetes

Advances in Medical Sciences

Volumn 59, Issue 1, 2014, Pages 39-43

  Szypowska, Agnieszka ^a   Stelmaszczyk Emmel, Anna ^a   Demkow, Urszula ^a   Łuczyński, Włodzimierz ^b  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Childhood diabetes; Diabetes type 1; T regulatory cells

Indexed keywords

C PEPTIDE; CD137 ANTIGEN; CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA; OX40 LIGAND; CD134 ANTIGEN; IL2RA PROTEIN, HUMAN; TNFRSF4 PROTEIN, HUMAN; TNFRSF9 PROTEIN, HUMAN;

ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MALE; PROTEIN EXPRESSION; SCHOOL CHILD; ADOLESCENT; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; FOLLOW UP; IMMUNOLOGY; INFANT; METABOLISM; PRESCHOOL CHILD; PROGNOSIS;

ADOLESCENT; ANTIGENS, CD137; CASE-CONTROL STUDIES; CD4-POSITIVE T-LYMPHOCYTES; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; FLOW CYTOMETRY; FOLLOW-UP STUDIES; HUMANS; INFANT; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; PROGNOSIS; RECEPTORS, OX40;

EID: 84907676969     PISSN: 18961126     EISSN: 18984002     Source Type: Journal    
DOI: 10.1016/j.advms.2013.07.003     Document Type: Article

References (24)

1. C.C. Patterson, G.G. Dahlquist, E. Gyürüs, A. Green, G. Soltész, and EURODIAB Study Group Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study Lancet 373 June (9680) 2009 2027 2033
2. + regulatory T cells during autoimmune diabetes J Exp Med 201 April (8) 2005 1333 1346
3. + T-cells expressing foxp3 Diabetes 54 April (4) 2005 1040 1047
4. T. So, S.W. Lee, and M. Croft Immune regulation and control of regulatory T cells by OX40 and 4-1BB Cytokine Growth Factor Rev 19 June-August (3-4) 2008 253 262
5. T.A. Fornari, P.B. Donate, C. Macedo, E.T. Sakamoto-Hojo, E.A. Donadi, and G.A. Passos Development of type 1 diabetes mellitus in nonobese diabetic mice follows changes in thymocyte and peripheral T lymphocyte transcriptional activity Clin Dev Immunol 2011 2011 158735
6. S. Tsai, A. Shameli, and P. Santamaria CD8+ T cells in type 1 diabetes Adv Immunol 100 2008 79 124
7. + T cells J Leukoc Biol 75 May (5) 2004 785 791
8. M.D. Vu, X. Xiao, W. Gao, N. Degauque, M. Chen, and A. Kroemer OX40 costimulation turns off Foxp3+ Tregs Blood 110 October (7) 2007 2501 2510
9. J. Endl, S. Rosinger, B. Schwarz, S.O. Friedrich, G. Rothe, and W. Karges Coexpression of CD25 and OX40 (CD134) receptors delineates autoreactive T-cells in type 1 diabetes Diabetes 55 January (1) 2006 50 60
10. T. Ito, Y.H. Wang, O. Duramad, S. Hanabuchi, O.A. Perng, and M. Gilliet OX40 ligand shuts down IL-10-producing regulatory T cells Proc Natl Acad Sci USA 103 August (35) 2006 13138 13143
11. M. Craig, A. Hattersley, and K. Donaghue Definition, epidemiology, diagnosis and classification of diabetes in children and adolescents Pediatr Diabetes 10 September (Suppl. 12) 2009 3 12
12. A.G. Ziegler, M. Pflueger, C. Winkler, P. Achenbach, B. Akolkar, and J.P. Krischer Accelerated progression from islet autoimmunity to diabetes is causing the escalating incidence of type 1 diabetes in young children J Autoimmun 37 August (1) 2011 3 7
13. P. Achenbach, E. Bonifacio, K. Koczwara, and A.G. Ziegler Natural history of type 1 diabetes Diabetes 54 December (Suppl. 2) 2005 S25 S31
14. A. Szypowska, A. Stelmaszczyk-Emmel, U. Demkow, and W. Luczyński Low frequency of regulatory T cells in the peripheral blood of children with type 1 diabetes diagnosed under the age of five Arch Immunol Ther Exp (Warsz) 60 August (4) 2012 307 313
15. A.D. Weinberg OX40: targeted immunotherapy - implications for tempering autoimmunity and enhancing vaccines Trends Immunol 23 February (2) 2002 102 109
16. B.C. Beaudette-Zlatanova, B. Whalen, D. Zipris, H. Yagita, J. Rozing, and H. Groen Costimulation and autoimmune diabetes in BB rats Am J Transplant 6 May (5 Pt 1) 2006 894 902
17. H.K. Sytwu, W.D. Lin, S.R. Roffler, J.T. Hung, H.S. Sung, and C.H. Wang Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model J Autoimmun 21 November (3) 2003 247 254
18. R.S. Mittler, J. Foell, M. McCausland, S. Strahotin, L. Niu, and A. Bapat Anti-CD137 antibodies in the treatment of autoimmune disease and cancer Immunol Res 29 1-3 2004 197 208
19. J. Irie, Y. Wu, K. Kachapati, R.S. Mittler, and W.M. Ridgway Modulating protective and pathogenic CD4+ subsets via CD137 in type 1 diabetes Diabetes 56 January (1) 2007 186 196
20. J.L. Cannons, G. Chamberlain, J. Howson, L.J. Smink, J.A. Todd, and L.B. Peterson Genetic and functional association of the immune signaling molecule 4-1BB (CD137/TNFRSF9) with type 1 diabetes J Autoimmun 25 August (1) 2005 13 20
21. W. Łuczyński, A. Stasiak-Barmuta, A. Juchniewicz, N. Wawrusiewicz-Kurylonek, E. Iłendo, and J. Kos The mRNA expression of pro- and anti-inflammatory cytokines in T regulatory cells in children with type 1 diabetes Folia Histochem Cytobiol 48 January (1) 2010 93 100
22. J. Komulainen, P. Kulmala, K. Savola, R. Lounamaa, J. Ilonen, and H. Reijonen Clinical, autoimmune, and genetic characteristics of very young children with type 1 diabetes. Childhood Diabetes in Finland (DiMe) Study Group Diabetes Care 22 December (12) 1999 1950 1955
23. M. Abdul-Rasoul, H. Habib, and M. Al-Khouly 'The honeymoon phase' in children with type 1 diabetes mellitus: frequency, duration, and influential factors Pediatr Diabetes 7 April (2) 2006 101 107
24. T. Brusko, C. Wasserfall, K. McGrail, R. Schatz, H.L. Viener, and D. Schatz No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes Diabetes 56 March (3) 2007 604 612